BioSpace News Archive

AbbVie (NYSE:ABBV) has been notified that TRC Capital Investment Corporation (TRC Capital) has commenced an unsolicited “mini-tender” offer, dated June 1, 2020 , to purchase up to 1,500,000 shares of AbbVie common stock at $88.05 per share. The offer price is approximately 4.99 percent below the closing price of the AbbVie co

In a project entitled “Implementation of Intensive Telehealth Intervention for Rural Patients with Uncontrolled Diabetes,” researchers revealed improved HbA1c levels among rural patients with poorly-controlled type 2 diabetes who participated in a comprehensive telehealth program.

June 12, 2020 22:40 UTC FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers GARDASIL ® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Now Approved for the Prevention of HPV-Related Cervical, Vaginal, Vulvar, Anal, Oropharyngeal and Other Head and Neck Cancers

The Department of Health and Human Services finalized a rule that revises 2016 provisions of the Obamacare section 1557 rule that had redefined discrimination “on the basis of sex” to include “gender identity” and “pregnancy termination.”

Eli Lilly and Company (NYSE: LLY) and Dermira, Inc., a wholly-owned subsidiary of Eli Lilly and Company, presented new data from the Phase 2b clinical trial of lebrikizumab in patients with moderate-to-severe atopic dermatiti

Shreya Ramesh, a Milton High School senior, from Milton, Georgia, and local winner of the Georgia BioGENEius Challenge, has taken the top prize at the fiercely competitive International BioGENEius Challenge

MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the year ended December 31, 2019, which are also available on SEDAR ( www.sedar.com ). The Company reported revenue of $860,248 for the year ended December 31, 2019, compared with revenue of $1,087,426 for the year ended December 31, 2018. Sales were lower in 2019 from both its SIAscopy skin assessment technology and therapeutic

Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development (R&D) funding in its Diabetes Group through an agreement to receive $337 million of funding from funds managed by Blackstone Life Sciences (“BXLS”) including co-investors, aimed a

New Research Suggests That Healthcare System Must Make Critical Changes in Current Treatment Models to Help Treat Lung Cancer Patients with COVID-19

Citigroup Global Markets Inc. (“Citigroup”), in its capacity as Joint Global Coordinator, notifies that stabilization measures have been undertaken in Calliditas Therapeutics AB’s (“Calliditas” or the “Company”) American Depositary Shares (“ADSs”), traded on The Nasdaq Global Select Market.